Literature DB >> 28410990

Tyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1α-Mediated Inflammatory Disease.

Prajwal Gurung1, Gaofeng Fan2, John R Lukens3, Peter Vogel4, Nicholas K Tonks2, Thirumala-Devi Kanneganti5.   

Abstract

Mice carrying a hypomorphic point mutation in the Ptpn6 gene (Ptpn6spin mice) develop an inflammatory skin disease that resembles neutrophilic dermatosis in humans. Here, we demonstrated that interleukin-1α (IL-1α) signaling through IL-1R and MyD88 in both stromal and immune cells drive inflammation in Ptpn6spin mice. We further identified SYK as a critical kinase that phosphorylates MyD88, promoted MyD88-dependent signaling and mediates dermatosis in Ptpn6spin mice. Our studies further demonstrated that SHP1 encoded by Ptpn6 binds and suppresses SYK activation to inhibit MyD88 phosphorylation. Downstream of SHP1 and SYK-dependent counterregulation of MyD88 tyrosine phosphorylation, we have demonstrated that the scaffolding function of receptor interacting protein kinase 1 (RIPK1) and tumor growth factor-β activated kinase 1 (TAK1)-mediating signaling were required to spur inflammatory disease. Overall, these studies identify SHP1 and SYK crosstalk as a critical regulator of MyD88 post-translational modifications and IL-1-driven inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-1α; IL-1β; MLKL; MyD88; Ptpn6; RIPK1; RIPK3; SHP1; SYK; TAK1; autoinflammation; myeloid cells; necrosis

Mesh:

Substances:

Year:  2017        PMID: 28410990      PMCID: PMC5501252          DOI: 10.1016/j.immuni.2017.03.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

1.  Neutrophils require SHP1 to regulate IL-1β production and prevent inflammatory skin disease.

Authors:  Ben A Croker; Rowena S Lewis; Jeff J Babon; Justine D Mintern; Dieter E Jenne; Donald Metcalf; Jian-Guo Zhang; Louise H Cengia; Joanne A O'Donnell; Andrew W Roberts
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

2.  "Viable motheaten," a new allele at the motheaten locus. I. Pathology.

Authors:  L D Shultz; D R Coman; C L Bailey; W G Beamer; C L Sidman
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

Review 3.  Genetic mouse models for bone studies--strengths and limitations.

Authors:  Florent Elefteriou; Xiangli Yang
Journal:  Bone       Date:  2011-08-31       Impact factor: 4.398

4.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Authors:  Jae-Hyuck Shim; Changchun Xiao; Amber E Paschal; Shannon T Bailey; Ping Rao; Matthew S Hayden; Ki-Young Lee; Crystal Bussey; Michael Steckel; Nobuyuki Tanaka; Gen Yamada; Shizuo Akira; Kunihiro Matsumoto; Sankar Ghosh
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

5.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.

Authors:  Yves Dondelinger; Wim Declercq; Sylvie Montessuit; Ria Roelandt; Amanda Goncalves; Inge Bruggeman; Paco Hulpiau; Kathrin Weber; Clark A Sehon; Robert W Marquis; John Bertin; Peter J Gough; Savvas Savvides; Jean-Claude Martinou; Mathieu J M Bertrand; Peter Vandenabeele
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

7.  RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.

Authors:  Christopher P Dillon; Ricardo Weinlich; Diego A Rodriguez; James G Cripps; Giovanni Quarato; Prajwal Gurung; Katherine C Verbist; Taylor L Brewer; Fabien Llambi; Yi-Nan Gong; Laura J Janke; Michelle A Kelliher; Thirumala-Devi Kanneganti; Douglas R Green
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

8.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

10.  Dietary modulation of the microbiome affects autoinflammatory disease.

Authors:  John R Lukens; Prajwal Gurung; Peter Vogel; Gordon R Johnson; Robert A Carter; Daniel J McGoldrick; Srinivasa Rao Bandi; Christopher R Calabrese; Lieselotte Vande Walle; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2014-09-28       Impact factor: 49.962

View more
  29 in total

1.  Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection.

Authors:  Benoit Briard; Rajendra Karki; R K Subbarao Malireddi; Anannya Bhattacharya; David E Place; Jayadev Mavuluri; Jennifer L Peters; Peter Vogel; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

2.  ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis.

Authors:  Sarang Tartey; Prajwal Gurung; Tejasvi Krishna Dasari; Amanda Burton; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

3.  Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease.

Authors:  Khalil Mallah; Jusal Quanico; Antonella Raffo-Romero; Tristan Cardon; Soulaimane Aboulouard; David Devos; Firas Kobeissy; Kazem Zibara; Michel Salzet; Isabelle Fournier
Journal:  Mol Cell Proteomics       Date:  2019-06-16       Impact factor: 5.911

Review 4.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

5.  SHP-1 (PTPN6) keeps the inflammation at bay: limiting IL-1α-mediated neutrophilic dermatoses by preventing Syk kinase activation.

Authors:  Ren-In You; Ching-Liang Chu
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

Review 6.  Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.

Authors:  Vishnu Hosur; Daniel A Skelly; Christopher Francis; Benjamin E Low; Vivek Kohar; Lisa M Burzenski; Mansoor M Amiji; Leonard D Shultz; Michael V Wiles
Journal:  Drug Discov Today       Date:  2020-05-05       Impact factor: 7.851

Review 7.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

8.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

9.  Cutting Edge: Dysregulated CARD9 Signaling in Neutrophils Drives Inflammation in a Mouse Model of Neutrophilic Dermatoses.

Authors:  Sarang Tartey; Prajwal Gurung; Parimal Samir; Amanda Burton; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2018-08-06       Impact factor: 5.422

Review 10.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.